These results were in line with previous findings, showing that PT promotes a TFEB-dependent up-regulation of HLA-A that in turns increases the immunogenicity of ovarian cancer cells, but at the same time it increases PD-L1 and PD-L2, inducing immune-anergy. The gene discussed is PDCD1LG2; the disease is ovarian cancer.